Most Read Articles
4 days ago
Prenatal and postpartum vitamin D supplementation does not appear to improve foetal or infant growth, a study reports.
6 days ago
Excessive daytime sleepiness appears to increase the long-term risk of amyloid β (Aβ) deposition, a recent study has shown.
6 days ago
Substituting diets high in carbohydrates with those high in monounsaturated fatty acids in the context of low saturated fatty acids do not appear to yield favourable effects on blood pressure, according to a meta-analysis.
2 days ago
Patients with chronic kidney disease appear to be at greater risk of developing type 2 diabetes mellitus (T2DM) compared with the general population, with predictors including poor baseline glycaemic control and family history of diabetes mellitus, a study has found.

Imiquimod cream trumps photodynamic therapy, 5-fluorouracil in superficial basal cell carcinoma

Jairia Dela Cruz
08 Mar 2018

Imiquimod cream appears to be more effective than both methyl aminolevulinate photodynamic therapy (MAL-PDT) and 5-fluorouracil cream in the long-term treatment of superficial basal cell carcinoma (sBCC), as shown in a recent study.

The study randomized 601 adult patients with a primary, histologically proven sBCC to receive MAL-PDT (n=202), imiquimod 5% cream (n=198) or 5-fluorouracil 5% cream (n=201). MAL-PDT involved two single treatments with a 1-week interval (fluence, 630 nm; dose, 37 J/cm2). Imiquimod was applied once daily for 5 consecutive days a week for 6 weeks, while 5-fluorouracil was applied twice daily for 4 weeks.

Over a median follow-up of 64 months, tumour recurrences occurred in 70 patients in the MAL-PDT group, 36 in the imiquimod group and 57 in the 5-fluorouracil group. The primary endpoint of the probability of tumour-free survival 5 years after treatment was 62.7 percent with MAL-PDT, 80.5 percent with imiquimod and 70.0 percent with 5-fluorouracil. [J Invest Dermatol 2018;138:527-533]

Cox proportional hazards models showed that the risk of treatment failure was significantly lower with imiquimod vs MAL-PDT (hazard ratio [HR], 0.48; 95 percent CI, 0.32–0.71; p<0.001) or 5-fluorouracil (HR, 0.65; 0.43–0.98; p=0.04). Furthermore, 5-fluorouracil was not inferior to MAL-PDT, having an HR of 0.74 (0.53–1.05; p=0.09).

The finding that tumour-free survival with imiquimod was 80.5 percent after 5 years of follow-up is in line with the results of a recent randomized controlled trial reporting a 5-year success rate of 83.8 percent with topical imiquimod cream vs surgical excision in 501 patients with sBCC. Two other studies on imiquimod treatment for sBCC reported 5-year success rates of 80.4 percent and 77.9 percent. [J Invest Dermatol 2017;137:614-619; Cutis 2010;85:318-324; Eur J Dermatol 2008;18:677-682]

“Based on the 5-year probabilities of remaining free from recurrence [in the current study], one recurrence can be prevented for every 5.6 patients (3.7–11.4) treated with imiquimod instead of MAL-PDT and for every 9.5 patients (5.2–57.4) treated with imiquimod instead of 5-fluorouracil,” the authors said.

Furthermore, while all three studied noninvasive therapies are considered an effective treatment for sBCC in the European guidelines, the present data suggest that 5% imiquimod cream should be the noninvasive treatment of choice, they continued. “PDT and 5-fluorouracil could be reserved for situations where there is a relative or absolute contraindication to using imiquimod.”

The study was limited by the number of patients lost to follow-up and the censoring of patient observations at exactly 36 months after treatment (the planned date). The authors pointed out a need to validate the current findings in multiple studies.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Prenatal and postpartum vitamin D supplementation does not appear to improve foetal or infant growth, a study reports.
6 days ago
Excessive daytime sleepiness appears to increase the long-term risk of amyloid β (Aβ) deposition, a recent study has shown.
6 days ago
Substituting diets high in carbohydrates with those high in monounsaturated fatty acids in the context of low saturated fatty acids do not appear to yield favourable effects on blood pressure, according to a meta-analysis.
2 days ago
Patients with chronic kidney disease appear to be at greater risk of developing type 2 diabetes mellitus (T2DM) compared with the general population, with predictors including poor baseline glycaemic control and family history of diabetes mellitus, a study has found.